Pseudomonas aeruginosa is an opportunistic pathogen that particularly poses a threat to immuno-compromised individuals. The species can undergo multicellular events that enhance its pathogenesis and resistance including some forms of motility and the formation of biofilm communities. Under external stresses, such as antibiotic treatment, immune cells, starvation or low oxygen supply, the pathogen can survive by acquiring new phenotypes that involve genetic mutations or morphological adaptations. As a result, P. aeruginosa can demonstrate enhanced multi-drug resistance and in many cases can be very difficult to eradicate. The focus of this work is to explore the structure activity relationships of small molecule inhibitors of the pathogenic...
The sharp rise in antimicrobial resistance has been matched by a decline in the identification and c...
The emergence of multidrug-resistance pathogens has called for alternative therapies to treat bacter...
The emergence of multidrug-resistance pathogens has called for alternative therapies to treat bacter...
Pseudomonas aeruginosa is an opportunistic pathogen that particularly poses a threat to immuno-compr...
Throughout the human history, the fight against bacterial infections had never stopped but the remed...
The fight against bacterial infections and innovations in antibiotic therapy has never halted throug...
The fight against bacterial infections and innovations in antibiotic therapy has never halted throug...
The outer membrane of Gram-negative bacteria presents an efficient barrier to the permeation of anti...
The outer membrane of Gram-negative bacteria presents an efficient barrier to the permeation of anti...
The virulence factor Type IV pili (T4P) are surface appendages used by the opportunistic pathogen Ps...
P. aeruginosa is an opportunistic human pathogen, responsible for acute and chronic infections in im...
Pseudomonas aeruginosa is capable of synthesizing polyhydroxyalkanoic acids (PHAs) and rhamnolipids,...
Multi-drug resistance (MDR) bacterial pathogens pose a threat to global health and warrant the disco...
Pseudomonas aeruginosa is a ubiquitous bacterium that can be found in most mesophilic aquatic and te...
Competitive interactions mediated by released chemicals (e.g., toxins) are prominent in multispecies...
The sharp rise in antimicrobial resistance has been matched by a decline in the identification and c...
The emergence of multidrug-resistance pathogens has called for alternative therapies to treat bacter...
The emergence of multidrug-resistance pathogens has called for alternative therapies to treat bacter...
Pseudomonas aeruginosa is an opportunistic pathogen that particularly poses a threat to immuno-compr...
Throughout the human history, the fight against bacterial infections had never stopped but the remed...
The fight against bacterial infections and innovations in antibiotic therapy has never halted throug...
The fight against bacterial infections and innovations in antibiotic therapy has never halted throug...
The outer membrane of Gram-negative bacteria presents an efficient barrier to the permeation of anti...
The outer membrane of Gram-negative bacteria presents an efficient barrier to the permeation of anti...
The virulence factor Type IV pili (T4P) are surface appendages used by the opportunistic pathogen Ps...
P. aeruginosa is an opportunistic human pathogen, responsible for acute and chronic infections in im...
Pseudomonas aeruginosa is capable of synthesizing polyhydroxyalkanoic acids (PHAs) and rhamnolipids,...
Multi-drug resistance (MDR) bacterial pathogens pose a threat to global health and warrant the disco...
Pseudomonas aeruginosa is a ubiquitous bacterium that can be found in most mesophilic aquatic and te...
Competitive interactions mediated by released chemicals (e.g., toxins) are prominent in multispecies...
The sharp rise in antimicrobial resistance has been matched by a decline in the identification and c...
The emergence of multidrug-resistance pathogens has called for alternative therapies to treat bacter...
The emergence of multidrug-resistance pathogens has called for alternative therapies to treat bacter...